Literature DB >> 11230731

Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?

K Harada1, K Tsuneyama, Y Sudo, S Masuda, Y Nakanuma.   

Abstract

The etiopathogenesis of primary biliary cirrhosis (PBC) remains speculative. Epithelioid granulomas are often found in the vicinity of damaged interlobular bile ducts in PBC, raising the possibility of a reaction to microbial materials. In this study, we tried to detect and identify bacterial DNA within granulomatous lesions in PBC. Using liver sections from 9 patients with PBC and 13 control livers, granuloma in portal tracts, portal tracts without granuloma, and adjacent hepatic parenchyma were selectively microdissected from sections, and then DNA was extracted from them. First, part of the bacterial 16S ribosomal RNA (rRNA) gene was amplified from DNA samples extracted from 5 PBC and 6 control livers, and their amplicons were sequenced for the identification of bacterial species. Several indigenous bacteria were identified. Among them, Propionibacterium acnes (P. acnes) was detected as a major clone in 20% to 50% of sequenced clones from granuloma of PBC, but the detection rate of P. acnes was 0% to 20% in those cloned from adjacent hepatic parenchyma of PBC. Then, a P. acnes-specific PCR was performed using all microdissected samples. Distinct PCR products were identified in epithelioid granuloma in all 9 PBC cases. The result that P. acnes DNA is present as a major clone in granulomas of PBC, suggest that P. acnes is involved in the pathogenesis of granuloma in PBC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230731     DOI: 10.1053/jhep.2001.22653

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis.

Authors:  Ikuko Haruta; Ken Kikuchi; Minoru Nakamura; Katsuhiko Hirota; Hidehito Kato; Hiroshi Miyakawa; Noriyuki Shibata; Yoichiro Miyake; Etsuko Hashimoto; Keiko Shiratori; Junji Yagi
Journal:  J Clin Immunol       Date:  2012-06-03       Impact factor: 8.317

2.  The immunopathology of liver granulomas in primary biliary cirrhosis.

Authors:  Zhengrui You; Qixia Wang; Zhaolian Bian; Yuan Liu; Xiaofeng Han; Yanshen Peng; Lei Shen; Xiaoyu Chen; Dekai Qiu; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2012-06-23       Impact factor: 7.094

3.  Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice.

Authors:  J J Wang; G-X Yang; W C Zhang; L Lu; K Tsuneyama; M Kronenberg; J L Véla; M Lopez-Hoyos; X-S He; W M Ridgway; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.

Authors:  K Harada; K Isse; Y Nakanuma
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

5.  Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection.

Authors:  Antonella Marangoni; Manuela Donati; Francesca Cavrini; Rita Aldini; Silvia Accardo; Vittorio Sambri; Marco Montagnani; Roberto Cevenini
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

6.  PPARγ ligand attenuates portal inflammation in the MRL-lpr mouse: a new strategy to restrain cholangiopathy in primary biliary cirrhosis.

Authors:  Yusuke Nozaki; Kenichi Harada; Takahiro Sanzen; Yasuni Nakanuma
Journal:  Med Mol Morphol       Date:  2013-02-09       Impact factor: 2.309

7.  Gut microbiota translocation promotes autoimmune cholangitis.

Authors:  Hong-Di Ma; Zhi-Bin Zhao; Wen-Tao Ma; Qing-Zhi Liu; Cai-Yue Gao; Liang Li; Jinjun Wang; Koichi Tsuneyama; Bin Liu; Weici Zhang; Yongjian Zhou; M Eric Gershwin; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2018-10-17       Impact factor: 7.094

Review 8.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

9.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.